Potentiation of Tissue Culture Rabies Vaccine by Adjuvants

Overview

Journal Am J Public Health Nations Health

Specialty Public Health

Date 1966 Dec 1

PMID 6006103

Citations 6

Authors

P FENJE

L PINTERIC

Affiliations

Soon will be listed here.

Citing Articles

Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization.

Natesan K, Isloor S, Vinayagamurthy B, Ramakrishnaiah S, Doddamane R, Fooks A Vaccines (Basel). 2023; 11(4).

PMID: 37112668 PMC: 10147034. DOI: 10.3390/vaccines11040756.

The present and future of rabies vaccine in animals.

Yang D, Kim H, Lee K, Song J Clin Exp Vaccine Res. 2013; 2(1):19-25.

PMID: 23596586 PMC: 3623496. DOI: 10.7774/cevr.2013.2.1.19.

Strains of rabies virus available for preparation of sylvatic rabies vaccines with special reference to vaccines prepared in cell culture.

Rhodes A Can Vet J. 1981; 22(8):262-6.

PMID: 7340931 PMC: 1789966.

Antibody and immunoglobulin response to antirabies vaccination in man.

Cho H, FENJE P, Sparkes J Infect Immun. 1972; 6(4):483-6.

PMID: 4628897 PMC: 422562. DOI: 10.1128/iai.6.4.483-486.1972.

Effect of administered interferon on rabies in rabbits.

POSTIC B, FENJE P Appl Microbiol. 1971; 22(3):428-31.

PMID: 4330317 PMC: 376326. DOI: 10.1128/am.22.3.428-431.1971.

References

FENJE P . A rabies vaccine from hamster kidney tissue cultures: preparation and evaluation in animals. Can J Microbiol. 1960; 6:605-9. DOI: 10.1139/m60-072. View

Haas R, THOMSSEN R . [On the developmental status of adjuvants commonly use in immunobiogy]. Ergeb Mikrobiol Immunitatsforsch Exp Ther. 1961; 34:27-119. View

HENNESSEN W, KOERNER L . [ON THE EFFECT AND STABILITY OF INACTIVATED POLIOVIRUS ANTIGENS IN VACCINES CONTAINING AL(OH)3]. Z Hyg Infektionskr. 1963; 149:359-64. View

Schmidt G, HENNESSEN W, MAHLING A . [COMPARATIVE TESTS ON THE ADSORPTION CHARACTERISTICS OF GAMMA-AL(OH)3 AND GAMMA-AL2O3]. Z Hyg Infektionskr. 1963; 149:341-58. View

LIPTON M, Freund J . The formation of complement fixing and neutralizing antibodies after the injection of inactivated rabies virus with adjuvants. J Immunol. 1950; 64(4):297-303. View

WIKTOR T, Fernandes M, KOPROWSKI H . CULTIVATION OF RABIES VIRUS IN HUMAN DIPLOID CELL STRAIN WI-38. J Immunol. 1964; 93:353-66. View

HILLEMAN M . A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. Am Rev Respir Dis. 1964; 90:683-706. DOI: 10.1164/arrd.1964.90.5.683. View

HIMMELWEIT F . Serological responses and clinical reactions to influenza virus vaccines. Br Med J. 1960; 2(5214):1690-4. PMC: 2098318. DOI: 10.1136/bmj.2.5214.1690. View

DAVENPORT F . Inactivated influenza virus vaccines. Past, present, and future. Am Rev Respir Dis. 1961; 83(2)Pt 2:146-56. DOI: 10.1164/arrd.1961.83.2P2.146. View

10.

DAVIS D, PHILIP R, Bell J, VOGEL J, Jensen D . Epidemiologic studies on influenza in familial and general population groups. 1951-1956. III. Laboratory observations. Am J Hyg. 1961; 73:138-47. DOI: 10.1093/oxfordjournals.aje.a120172. View

11.

McClelland L, Hampil B, Hamparian V, POTASH L, KETLER A, HILLEMAN M . Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. J Immunol. 1961; 87:134-8. View

12.

Grafe A, KUHN R . [The potentiation of vaccines by aluminum oxide adsorption. 1. Aluminum oxide-poliovaccine]. Arzneimittelforschung. 1962; 12:33-7. View

13.

WILNER B, EVERS M, TROUTMAN H, TRADER F, McLean I . VACCINE POTENTIATION BY EMULSIFICATION WITH PURE HYDROCARBON COMPOUNDS. J Immunol. 1963; 91:210-29. View

14.

Kissling R, Reese D . ANTI-RABIES VACCINE OF TISSUE CULTURE ORIGIN. J Immunol. 1963; 91:362-8. View

15.

BEEBE G, SIMON A, VIVONA S . FOLLOW-UP STUDY ON ARMY PERSONNEL WHO RECEIVED ADJUVANT INFLUENZA VIRUS VACCINE 1951-1953. Am J Med Sci. 1964; 247:385-406. DOI: 10.1097/00000441-196404000-00001. View

16.

UJHAZY V . CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES. Br Med J. 1964; 2(5404):267-71. PMC: 1815579. DOI: 10.1136/bmj.2.5404.267. View

17.

Hobson D, Lane C, Beare A, CHIVERS C . SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES. Br Med J. 1964; 2(5404):271-4. PMC: 1815622. DOI: 10.1136/bmj.2.5404.271. View

18.

WOODHOUR A, METZGAR D, STIM T, TYTELL A, HILLEMAN M . NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med. 1964; 116:516-23. DOI: 10.3181/00379727-116-29295. View

19.

PECK H, WOODHOUR A, METZGAR D, McKINNEY S, HILLEMAN M . NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS. Proc Soc Exp Biol Med. 1964; 116:523-30. DOI: 10.3181/00379727-116-29296. View